-
US aircraft carrier departs Thailand after port call
-
Jovic 'loses sanity five times over' to oust friend Eala in US Open epic
-
Haze emergency grips Malaysian Borneo town
-
China's memories of Mao fade to nostalgia 50 years after his death
-
Messi creates both Miami goals in 2-2 draw with Atlanta
-
US envoys discuss with Putin 'substantive' plans for steps to end Ukraine war
-
Rybakina books US Open fourth-round berth, inches closer to No. 1
-
Zheng stuns Keys as US Open upsets dim American hopes
-
Sobering reality: Curbs on alcohol in northeast Syria cause discontent
-
Jovic 'loses sanity five times over' to oust Eala and book Gauff clash
-
Wobbly Osaka 'shocked' to battle past Mertens and reach last 16
-
'Like a jewel': Japan's luxury ice revered by bars worldwide
-
Indian Oscar-nominated filmmaker turns camera on his cancer
-
'The flood is coming': How a Nepal principal saved 900 students
-
Argentina 'let off hook' by Australia as Kiss's winning run ends
-
Kiss's winning run ends as Argentina hold Australia to draw
-
Argentina threatens to sanction oil projects around Falklands
-
Alcaraz excited to face 'dangerous' Paul for US Open quarter-final berth
-
Gauff into round four at US Open after straight-set win
-
Prince William to represent King Charles III at Norway late King Harald's funeral
-
Bordeaux hammer Racing in Top 14 start as Bielle-Biarrey extends deal
-
Inter and Roma roar back to win thrillers and share top spot
-
Zheng, Potapova pull off upsets to reach US Open last 16
-
Don't stop them now: fans party for Freddie Mercury's 80th birthday
-
Swiatek into US Open fourth round in tight two-setter
-
AFP photographer wins top prize for Madagascar protest coverage
-
Werro wins in Brussels, as Russell and Dos Santos shine
-
Keys: 'I felt like I couldn't play tennis'
-
Kolbe breaks jaw and shoulder injury sidelines Savea
-
Simmonds stars as Pau upset Montpellier
-
US military strikes oil tankers as Iran vows tougher reprisals
-
Inter roar back in five-goal thriller with Napoli
-
Zheng rallies to stun Keys, Anisimova out in US Open third round
-
Haaland keeps Man City perfect in Premier League, blunt Spurs held
-
Bayern held to draw by stubborn Schalke
-
Hamilton worried by Ferrari pace while Antonelli prepares for a fight
-
Lens lose again ahead of Champions League date
-
Vuelta stage 15 shortened due to extreme heat, Mas consolidates lead
-
Olympic champion Zheng storms home to reach US Open last 16
-
Putin meets US envoys for Ukraine war talks
-
Big-spending Spurs must make better attacking decisions, says De Zerbi
-
Modric available for Croatia in Nations League
-
South Africa dominate New Zealand in second half to lead series
-
Potapova upsets 2025 US Open runner-up Anisimova
-
Kiefer Sutherland still in action, but ibuprofen lending helping hand
-
Gasly a 'class act' says Alpine boss after Monza pole
-
'Are we ready?' Oasis film captures band's frosty reunion
-
Athletic Bilbao crush Simeone's flat Atletico
-
Commemoration held for late Bosnian Serb war criminal Ratko Mladic
-
Stay far from battlefield, warns Japanese director in Vietnam War film
Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office
Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announced the filing of two patents to protect its groundbreaking delivery systems. These patents are set to revolutionize the company's product lines and enhance the proprietary transport of SOD and other powerful ingredients throughout the body to enhance wellness, and promote health and anti aging from cellular levels.
Advancing Supplement Technology
The patent-pending formulations represent a significant leap forward in supplement technology worldwide. Cellev8's delivery mechanisms have proven effect with thousands of people by focusing on reducing oxidative stress and providing superior cellular protection in the body. Cellev8 revolutionizes supplement effectiveness by employing advanced delivery mechanisms to enhance SOD absorption and combining it with powerful, targeted ingredients. This innovative approach maximizes the potency and precision of their products, delivering optimal benefits to specific areas of the body. These innovations are expected to further solidify the company's position as a leader in the wellness industry.
Key Highlights of the Patent Filings:
• Enhanced Ingredient Delivery: The new systems are designed to improve the absorption and utilization of key ingredients, including the company's flagship SOD formulations.
• Proprietary Transport Mechanisms: Cellev8's unique approach ensures that active compounds reach their intended targets more efficiently within the body.
• Broad Application: The patents cover delivery systems applicable across Cellev8's entire product range, including their popular inflammation and recovery gummies.
Impact on Product Lines
Michael Ferraro, CEO of Cellev8 Nutrition, commented on the patent filings: "These patents represent a culmination of our research and development efforts. They will not only protect our intellectual property but also pave the way for more effective and innovative wellness solutions for our customers. Imagine supplements that not only deliver powerful key ingredients more efficiently but also provides a precisely tailored blend of nutrients and critical anti-oxidants to support your body's unique needs. That's the Cellev8 difference! With our innovative approach, we're not just creating supplements - we're crafting personalized solutions for optimal health and vitality.."
The new delivery systems are expected to enhance the performance of Cellev8's existing products, including:
• Inflammation & Recovery Gummies
• Focus & Memory Gummies
• GLP1 Support Gummies
Future Prospects
With these patent filings, Cellev8 Nutrition is poised to expand its market presence with a lineup of additional products and potentially collaborate with larger nutraceutical and pharmaceutical companies interested in leveraging the benefits of their enhanced delivery process.
The company continues to focus on developing cutting-edge wellness products that promote health and vitality, serving thousands of customers, including over 40 professional and collegiate athletic teams, clients of FDA certified Zyppah products and patients/clients of publicly traded FDA approved sleep apnea company Vivos Therapeutics Inc.
For more information about Cellev8 Nutrition Inc and its innovative product line, visit www.cellev8.com
W.Nelson--AT